BNP Paribas upgraded Eurofins Scientific (ERFSF) to Outperform from Underperform with a price target of EUR 75, up from EUR 51.50. The company is entering “the sweet spot” of higher growth and margins, the analyst tells investors in a research note.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential